| MeSH term | MeSH ID | Detail |
|---|---|---|
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Peripheral Nervous System Diseases | D010523 | 33 associated lipids |
| Osteoarthritis, Knee | D020370 | 13 associated lipids |
| Multiple Sclerosis | D009103 | 13 associated lipids |
| Nervous System Diseases | D009422 | 37 associated lipids |
| Ataxia | D001259 | 20 associated lipids |
| Brain Edema | D001929 | 20 associated lipids |
| Infarction, Middle Cerebral Artery | D020244 | 35 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Epilepsy | D004827 | 35 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lam PM et al. | Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. | 2008 | Anal. Biochem. | pmid:18555789 |
| Horvath G et al. | The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. | 2008 | Pain | pmid:17533116 |
| Zolese G et al. | Effect of acylethanolamides on lipid peroxidation and paraoxonase activity. | 2008 | Biofactors | pmid:19478424 |
| Panagis G et al. | Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. | 2008 | Curr Drug Abuse Rev | pmid:19630731 |
| Ortar G et al. | Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. | 2008 | Eur J Med Chem | pmid:17452063 |
| Malvindi MA et al. | Rod-shaped nanocrystals elicit neuronal activity in vivo. | 2008 | Small | pmid:18844306 |
| Liu J et al. | Multiple pathways involved in the biosynthesis of anandamide. | 2008 | Neuropharmacology | pmid:17631919 |
| Shaladi AM et al. | [Cannabinoids in the control of pain]. | 2008 | Recenti Prog Med | pmid:19388223 |
| Xiong W et al. | Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. | 2008 | Mol. Pharmacol. | pmid:17993512 |
| Hill MN et al. | Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. | 2008 | Hippocampus | pmid:18058925 |
| Egertová M et al. | Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. | 2008 | J. Comp. Neurol. | pmid:18067139 |
| Rossi C et al. | Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. | 2008 | Eur. J. Clin. Pharmacol. | pmid:18004553 |
| Di Marzo V et al. | The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. | 2008 | Br. J. Pharmacol. | pmid:18223666 |
| Simon GM and Cravatt BF | Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. | 2008 | J. Biol. Chem. | pmid:18227059 |
| Burstein S | The elmiric acids: biologically active anandamide analogs. | 2008 | Neuropharmacology | pmid:18187165 |
| Maccarrone M et al. | Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. | 2008 | Nat. Neurosci. | pmid:18204441 |
| Paradisi A et al. | Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. | 2008 | J. Biol. Chem. | pmid:18165231 |
| Jackson SN et al. | Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. | 2008 | Eur. J. Pharmacol. | pmid:18242598 |
| Butt C et al. | Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. | 2008 | J. Neurochem. | pmid:18194436 |
| Oddi S et al. | Evidence for the intracellular accumulation of anandamide in adiposomes. | 2008 | Cell. Mol. Life Sci. | pmid:18213445 |
| Baldassano S et al. | Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. | 2008 | Eur. J. Pharmacol. | pmid:18234188 |
| Starowicz KM et al. | Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. | 2008 | Obesity (Silver Spring) | pmid:18239598 |
| Gorzalka BB et al. | Endocannabinoid modulation of male rat sexual behavior. | 2008 | Psychopharmacology (Berl.) | pmid:17694389 |
| Rueda-Orozco PE et al. | A potential function of endocannabinoids in the selection of a navigation strategy by rats. | 2008 | Psychopharmacology (Berl.) | pmid:17805517 |
| Engeli S et al. | Peripheral endocannabinoid system activity in patients treated with sibutramine. | 2008 | Obesity (Silver Spring) | pmid:18356837 |
| Kurtuncu M et al. | Effects of cocaine in 5-lipoxygenase-deficient mice. | 2008 | J Neural Transm | pmid:18327533 |
| Habayeb OM et al. | Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. | 2008 | JAMA | pmid:18334688 |
| Oláh M et al. | The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG. | 2008 | Mol. Cell. Endocrinol. | pmid:18308464 |
| Potvin S et al. | Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. | 2008 | J. Psychopharmacol. (Oxford) | pmid:18308802 |
| Hill MN et al. | Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. | 2008 | Pharmacopsychiatry | pmid:18311684 |
| Migliarini B and Carnevali O | Anandamide modulates growth and lipid metabolism in the zebrafish Danio rerio. | 2008 | Mol. Cell. Endocrinol. | pmid:18342434 |
| Wise LE et al. | Evaluation of fatty acid amides in the carrageenan-induced paw edema model. | 2008 | Neuropharmacology | pmid:17675189 |
| De Oliveira Alvares L et al. | Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. | 2008 | Neurobiol Learn Mem | pmid:18342551 |
| Palkovits M et al. | Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. | 2008 | Neuroscience | pmid:18343585 |
| Fezza F et al. | Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation. | 2008 | J. Lipid Res. | pmid:18316795 |
| Gertsch J | Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system. | 2008 | Planta Med. | pmid:18275004 |
| Roberts LA et al. | Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. | 2008 | Neuropharmacology | pmid:17631916 |
| Gonçalves P et al. | Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells. | 2008 | Pharmacology | pmid:18431074 |
| McFarland MJ et al. | RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. | 2008 | Mol. Pharmacol. | pmid:18436710 |
| Nomura DK et al. | Activation of the endocannabinoid system by organophosphorus nerve agents. | 2008 | Nat. Chem. Biol. | pmid:18438404 |
| Ortar G et al. | New tetrazole-based selective anandamide uptake inhibitors. | 2008 | Bioorg. Med. Chem. Lett. | pmid:18424134 |
| Bisogno T | Endogenous cannabinoids: structure and metabolism. | 2008 | J. Neuroendocrinol. | pmid:18426492 |
| Capasso R and Izzo AA | Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. | 2008 | J. Neuroendocrinol. | pmid:18426498 |
| Ahn K et al. | Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. | 2008 | Chem. Rev. | pmid:18429637 |
| Engel MA et al. | Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide. | 2008 | J. Physiol. Pharmacol. | pmid:19212003 |
| Mallat A and Lotersztajn S | Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis. | 2008 | Diabetes Metab. | pmid:19195630 |
| Palmer JA et al. | Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. | 2008 | Neuroscience | pmid:18541380 |
| Yang Z et al. | Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. | 2008 | Biochem. Pharmacol. | pmid:18755158 |
| Di Marzo V | Endocannabinoids: synthesis and degradation. | 2008 | Rev. Physiol. Biochem. Pharmacol. | pmid:18481028 |
| Pertwee RG | Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. | 2008 | Addict Biol | pmid:18482430 |
| Rueda-Orozco PE et al. | Impairment of endocannabinoids activity in the dorsolateral striatum delays extinction of behavior in a procedural memory task in rats. | 2008 | Neuropharmacology | pmid:18501388 |
| Di Filippo M et al. | Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. | 2008 | J. Neurol. Neurosurg. Psychiatr. | pmid:18535023 |
| Ashton JC et al. | Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. | 2008 | Curr. Med. Chem. | pmid:18537620 |
| Njie YF et al. | N-arachidonylethanolamide-induced increase in aqueous humor outflow facility. | 2008 | Invest. Ophthalmol. Vis. Sci. | pmid:18539938 |
| Feizi A et al. | The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. | 2008 | Exp. Toxicol. Pathol. | pmid:18571910 |
| Woo DH et al. | Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). | 2008 | Mol Pain | pmid:18826653 |
| Habayeb OM et al. | Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. | 2008 | Endocrinology | pmid:18599552 |
| DeMorrow S et al. | The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18832445 |
| Waldeck-Weiermair M et al. | Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. | 2008 | J. Cell. Sci. | pmid:18445684 |
| Resstel LB et al. | Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. | 2008 | Psychopharmacology (Berl.) | pmid:18446325 |
| Cippitelli A et al. | Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. | 2008 | Psychopharmacology (Berl.) | pmid:18446329 |
| Bambico FR and Gobbi G | The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. | 2008 | Expert Opin. Ther. Targets | pmid:18851692 |
| Liu HY et al. | [Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors]. | 2008 | Zhonghua Gan Zang Bing Za Zhi | pmid:18578993 |
| Dembiński A et al. | Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. | 2008 | Eur. J. Pharmacol. | pmid:18593574 |
| Khasabova IA et al. | A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. | 2008 | J. Neurosci. | pmid:18971457 |
| Hill MN et al. | Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. | 2008 | J Neural Transm | pmid:18974922 |
| Lisboa SF et al. | Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. | 2008 | Eur. J. Pharmacol. | pmid:18691568 |
| Currie S et al. | IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. | 2008 | J. Mol. Cell. Cardiol. | pmid:18692061 |
| Turco MY et al. | High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. | 2008 | Hum. Reprod. | pmid:18614613 |
| Maccarrone M | Anandamide as a marker of human disease. | 2008 | JAMA | pmid:18632539 |
| Hill MN et al. | Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. | 2008 | J. Neurochem. | pmid:18643796 |
| Kudo R and Hatake K | [Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)]. | 2008 | Nihon Arukoru Yakubutsu Igakkai Zasshi | pmid:18646646 |
| Maione S et al. | Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. | 2008 | Br. J. Pharmacol. | pmid:18660824 |
| Fowler CJ | "The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. | 2008 | Curr. Pharm. Des. | pmid:18781976 |
| McPartland JM et al. | Cannabimimetic effects modulated by cholinergic compounds. | 2008 | Addict Biol | pmid:18782385 |
| Ferreri C et al. | Synthesis of all-trans anandamide: a substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation. | 2008 | Bioorg. Med. Chem. | pmid:18782671 |
| Rácz I et al. | Anandamide effects on 5-HT(3) receptors in vivo. | 2008 | Eur. J. Pharmacol. | pmid:18775693 |
| Neelands TR et al. | Elevated temperatures alter TRPV1 agonist-evoked excitability of dorsal root ganglion neurons. | 2008 | Inflamm. Res. | pmid:18777111 |
| Placzek EA et al. | Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. | 2008 | J. Neurochem. | pmid:18778304 |
| Scherma M et al. | Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18725543 |
| Ho WS et al. | 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. | 2008 | Br. J. Pharmacol. | pmid:18695637 |
| Woodward DF et al. | The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. | 2008 | Pharmacol. Ther. | pmid:18700152 |
| Williams JL et al. | K+ channel inhibition modulates the biochemical and morphological differentiation of human placental cytotrophoblast cells in vitro. | 2008 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:18703414 |
| Moezi L et al. | Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18703639 |
| de Oliveira Alvares L et al. | Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. | 2008 | Neuroscience | pmid:18554811 |
| Cella M et al. | Dual effect of anandamide on rat placenta nitric oxide synthesis. | 2008 | Placenta | pmid:18561998 |
| Placzek EA et al. | Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. | 2008 | Neuropharmacology | pmid:18760289 |
| Nakata M and Yada T | Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors. | 2008 | Regul. Pept. | pmid:17884194 |
| Haller VL et al. | Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. | 2008 | Eur. J. Pharmacol. | pmid:18762181 |
| Astarita G et al. | Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. | 2008 | J. Lipid Res. | pmid:17957091 |
| Qin N et al. | TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. | 2008 | J. Neurosci. | pmid:18550765 |
| Lehtonen M et al. | Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes. | 2008 | Chem. Biodivers. | pmid:19035572 |
| Scherma M et al. | The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. | 2008 | Neuropharmacology | pmid:17904589 |
| Bjursell M et al. | Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. | 2008 | Am. J. Physiol. Endocrinol. Metab. | pmid:18029443 |
| Butler RK et al. | Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. | 2008 | Pain | pmid:19004548 |
| Williams MA et al. | The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. | 2008 | J. Physiol. (Lond.) | pmid:18063665 |
| Gyires K and Zádori Z | [Analysis of central mechanisms involved in gastric mucosal integrity]. | 2008 | Neuropsychopharmacol Hung | pmid:18956615 |
| Justinova Z et al. | Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. | 2008 | Biol. Psychiatry | pmid:18814866 |
| Thiemann G et al. | The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. | 2008 | Behav. Brain Res. | pmid:17988751 |
| Correa F et al. | Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). | 2008 | Biochem. J. | pmid:17961121 |